Julie Buring, ScD
Dr. Julie E. Buring is Professor of Medicine at Harvard Medical School and Brigham and Women‘s Hospital and Professor of Epidemiology at the Harvard T.H. Chan School of Public Health.
The primary focus of Dr. Buring’s research is the epidemiology of the prevention of chronic diseases, especially cardiovascular disease and cancer, and with a primary methodologic focus on randomized clinical trials. Dr. Buring has been involved in the design, conduct, analysis, and interpretation of a number of large-scale randomized clinical trials and their observational follow-up. She served as the Principal Investigator of the Women’s Health Study trial, evaluating the balance of benefits and risks of low dose aspirin and vitamin E in the primary prevention of cardiovascular disease and cancer among 40,000 female health professionals, and is currently co-Principal Investigator of the extended observational follow-up of the participants. She is also co-Principal Investigator of a just completed trial of vitamin D and fish oil in the primary prevention of cardiovascular disease and cancer (VITAL) among 26,000 participants, which has just begun its observational follow-up phase. She has also served as co-Investigator of both the Physicians' Health Study I and II, which evaluated in large-scale randomized trials the preventive roles of low-dose aspirin, beta-carotene, vitamin E, vitamin C, and a multivitamin on cardiovascular disease, cancer, vision, and cognitive function.
Dr. Buring has longstanding and substantial commitments to teaching and training in epidemiology, both nationally and internationally. She serves as Chair of the Harvard Medical School Institutional Review Board, and is a member of the National Cancer Institute Board of Scientific Counselors for Clinical Science and Epidemiology.